Barbora Fiserova

Ms. Barbora Fiserova

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 November 2021 in Frontiers in Pharmacology
Verified
Journal Article
Open access
TKTomas Kudera
Tomas Kudera
Barbora FiserovaBarbora Fiserova
Barbora Fiserova
MKMarie Korytakova
Marie Korytakova
IDIvo Doskocil
Ivo Doskocil
HSHana Salmonova
Hana Salmonova
Ladislav KokoskaLadislav Kokoska
Ladislav Kokoska
Bacterial diarrhea remains a global health problem, especially in developing tropical countries. Moreover, dysbiosis caused by diarrheagenic bacteria and inappropriate antimicrobial treatment has been associated with intestinal carcinogenesis. Despite the rich tradition of the use of herbs for the treatment of gastrointestinal disorders in Cambodian and Philippine folk medicine, many of them have not yet been systematically studied for their in vitro selective inhibitory effects on intestinal bacteria and cells. In the present study, in vitro inhibitory activities of 35 ethanolic extracts derived from 32 Cambodian and Philippine medicinal plants were determined by broth microdilution method against 12 pathogenic bacteria. Furthermore, cytotoxicity against intestinal cancer cells (Caco-2 and HT-29) using thiazolyl blue tetrazolium bromide cytotoxicity assay and safety to six beneficial intestinal bacteria (bifidobacteria and lactobacilli) and intestinal normal cells (FHs 74 Int) were determined for the antimicrobially active extracts. Selectivity indices (SIs) were calculated among the averages of minimum inhibitory concentrations (MICs), half-maximal inhibitory concentrations (IC50), and 80% inhibitory concentrations of proliferation (IC80) for each type of the tested agents. The extracts of Artocarpus blancoi (Elmer) Merr. (Moraceae), Ancistrocladus tectorius (Lour.) Merr. (Ancistrocladaceae), and Pentacme siamensis (Miq.) Kurz (Dipterocarpaceae) produced significant growth-inhibitory effects (MICs = 32–512 μg/ml) against intestinal pathogenic bacteria at the concentrations nontoxic to normal intestinal cells (IC80 values >512 μg/ml; SIs = 0.11–0.2). Moreover, the extract of P. siamensis (Miq.) Kurz was relatively safe to beneficial bacteria (MICs ≥512 μg/ml; SI = 0.1), and together with A. blancoi (Elmer) Merr., they selectively inhibited intestinal cancer cells (IC50 values ≥51.98 ± 19.79 μg/ml; SIs = 0.3 and 0.6). Finally, a strong selective antiproliferative effect on cancer cells (IC50 values 37.89 ± 2.68 to 130.89 ± 13.99 μg/ml; SIs = 0.5) was exerted by Ehretia microphylla Lam. (Boraginaceae), Lagerstroemia cochinchinensis Pierre ex Gagnep. (Lythraceae), and Melastoma saigonense (Kuntze) Merr. (Melastomataceae) (leaves with flower buds). The results suggest that the above-mentioned species are promising materials for the development of new selective antibacterial and antiproliferative agents for the treatment of infectious diarrhea and associated intestinal cancer diseases. However, further research is needed regarding the isolation and identification of their active constituents.

18 June 2026 in Molecules
Verified
Journal Article
Open access
PDF file
Barbora FiserovaBarbora Fiserova
Barbora Fiserova
Tomas KuderaTomas Kudera
Tomas Kudera
HSHana Salmonová
Hana Salmonová
TNTereza Navrátilová
Tereza Navrátilová
Ladislav KokoskaLadislav Kokoska
Ladislav Kokoska
Colorectal cancer (CRC) has been increasingly associated with gut microbiota dysbiosis and the presence of specific bacterial pathogens. This study evaluated the in vitro growth-inhibitory activity of 18 biologically active compounds, including phytochemicals, synthetic analogs, and clinically used antibiotics, against CRC-associated bacterial strains. Minimum inhibitory concentrations (MICs) were determined using the broth microdilution method and analyzed in relation to chemical structure. Conventional antibiotics, particularly tetracycline and ciprofloxacin, exhibited the strongest antibacterial activity. Among non-antibiotic compounds, nitroxoline and carbadox showed moderate activity, whereas quaternary benzylisoquinoline-derived alkaloids and polyphenols were less effective. Structure–activity relationship analysis suggested that aromatic heterocyclic scaffolds, electron-withdrawing substituents, and metal-chelating groups contribute to antibacterial potency. We obtained novel MIC data for several compounds, including ferron and oxyquinoline, against underexplored CRC-associated bacterial strains. These findings expand current knowledge of the antibacterial activity of structurally diverse compounds against CRC-associated bacteria and provide a basis for future studies on microbiota-targeted antimicrobial strategies.

3 October 2026 in Foods
Verified
Journal Article
Open access
PDF file
Tomas KuderaTomas Kudera
Tomas Kudera
DBDiana Karina Baigts-Allende
Diana Karina Baigts-Allende
Barbora FiserovaBarbora Fiserova
Barbora Fiserova
Ladislav KokoskaLadislav Kokoska
Ladislav Kokoska
Colorectal cancer is increasingly linked to diet-induced gut microbiota modulations, whereas the role of oncogenic bacteria is discussed. This study investigated the in vitro growth-modulatory effects of hot-water extracts of six stimulant beverages, namely Aspalathus linearis (rooibos), Coffea arabica, Coffea canephora (coffee), Camellia sinensis var. assamica, C. sinensis var. sinensis (tea) and Ilex paraguariensis (yerba mate) against six colorectal cancer-associated bacteria. Although no minimum inhibitory concentration (MIC) was detected (MIC > 512 µg/mL), growth kinetics analysis revealed modulations in the case of several strains. At the concentration 512 µg/mL, C. sinensis var. assamica and I. paraguariensis modulated the growth (41–56%) and prolonged the lag phase (61–128 min) of Clostridium septicum. The same concentration of both extracts modulated Fusobacterium necrophorum (26–27%), whereas I. paraguariensis extended the lag phase by 72 and 21 min in the cases of Peptostreptococcus anaerobius and Escherichia coli, respectively. Both C. sinensis varieties also reduced the growth of Streptococcus bovis (49–60%), while some treatments stimulated the growth of E. coli. These findings demonstrate in vitro growth modulation of selected colorectal cancer-associated bacteria, especially C. sinensis and I. paraguariensis, and warrant validation using multiple strains, independently replicated assays, chemically characterized extracts, and more physiologically relevant microbial models.